Why This Session Matters
Precision medicine is transforming how we diagnose, monitor, and treat cancer. At Cancer 2025, you’ll have a rare opportunity to hear Dr. Rajvir Dahiya—University of California San Francisco School of Medicine, USA—present in person on “A Novel mRNA Genomic Technology for Precision Medicine, Cancer Diagnosis, Prognosis & Treatment Follow-Up.”
What You’ll Learn
• How cutting-edge mRNA genomic profiling pinpoints actionable mutations in real time
• New algorithms that predict patient prognosis and guide therapy selection
• Case studies demonstrating improved survival and reduced recurrence rates
• Practical steps to integrate genomic data into clinical workflows
About Dr. Rajvir Dahiya
Dr. Rajvir Dahiya—PhD (PGIMER India), MD (Kagoshima Univ., Japan), DSc (Osaka Univ., Japan)—is a globally acclaimed molecular oncologist and founding Director of the Urology Oncology Research Center at UCSF/VA Medical Center, where he served for 34 years before becoming Professor Emeritus. He has authored 550+ peer-reviewed papers, earned 35,500+ citations with a D-index of 107, and led 99 NIH and VA-funded projects that advanced mRNA-based diagnostics and precision oncology, resulting in multiple patents.
Event Snapshot
• Conference: International Conference on Cancer Science & Research (Cancer 2025)
• Date: 17-19, November 2025
• Location: Singapore and Online
Secure Your Seat
Spaces for this high-impact session are limited. Register now to guarantee your spot and gain full conference access: https://cancer.miconferences.com/register
Join the Conversation:
• Twitter: https://x.com/CancerWorldConf
• Email: cancer@mathewsconference.com
• Whatsapp: +1 (424) 377 0967
#Oncology #mRNA #CancerResearch #PrecisionMedicine #CancerConference #Cancer2025 #GenomicTechnology #UCSF #SingaporeEvents
Don’t miss this chance to witness a breakthrough in precision oncology, learn directly from a global leader, and connect with peers shaping the future of cancer care. We look forward to welcoming you to Cancer 2025!